🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: FLAG-IDA (Granulocyte-Colony Stimulating Factor (G-CSF), Fludarabine, Cytarabine, Idarubicin)

Found 20 matching trials

A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old

PHASE3

The study will include newly-diagnosed AML patients, not suffering acute pr...

Status

Unknown

Location

Weill Cornell Medicine

Start Date

2017-07-03

Trial ID

NCT03257241

Treatments Being Tested

A arm (DA-90)B arm (DAC)A arm (CLAG-M)B arm (FLAG-IDA)

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

PHASE1

This phase I/II trial studies the safety, side effects, and best dose of de...

Status

Recruiting

Location

Fred Hutch/University of Washington Cancer Consortium

Start Date

2025-09-23

Trial ID

NCT06928662

Treatments Being Tested

Decitabine Bone Marrow Aspiration Bone Marrow Biopsy Chest Radiography Cytarabine Echocardiography Test Filgrastim Fludarabine Hematopoietic Cell Transplantation Idarubicin Multigated Acquisition Scan Pheresis Total-Body Irradiation Biospecimen Collection

HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML

PHASE3

A randomized，multicenter, open-label Phase III, clinical study is conducted...

Status

Recruiting

Location

the First Affiliated Hospital,College of Medicine,Zhejiang University

Start Date

2023-03-03

Trial ID

NCT05586074

Treatments Being Tested

Clifutinib LoDAC Azacitidine Decitabine Ara-C±IDA FLAG-IDA

A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia

PHASE2

The overall aim of this study is to determine if epigenetic priming with a ...

Status

Active Not Recruiting

Location

Children's Hospital of Central California

Start Date

2017-06-15

Trial ID

NCT03164057

Treatments Being Tested

Azacitidine Decitabine Cytarabine Daunorubicin Etoposide ITMHA Idarubicin Fludarabine Mitoxantrone Erwinia asparaginase Sorafenib G-CSF Dexrazoxane Stem Cell Transplant Asparaginase Erwinia Chrysanthemi, Recombinant-Rywn

A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation

PHASE3

The purpose of this study was to determine the clinical benefit of ASP2215 ...

Status

Completed

Location

Site US10011

Start Date

2015-10-20

Trial ID

NCT02421939

Treatments Being Tested

gilteritinib LoDAC (Low Dose Cytarabine)Azacitidine MEC (Mitoxantrone, Etoposide, Cytarabine)FLAG-IDA (Granulocyte-Colony Stimulating Factor (G-CSF), Fludarabine, Cytarabine, Idarubicin)

Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML

PHASE1

The goal of Phase 1b is to establish the safety of asciminib in combination...

Status

Not Yet Recruiting

Location

UT MD Anderson

Start Date

2026-11-30

Trial ID

NCT07604233

Treatments Being Tested

Fludarabine Cytarabine Idarubicin Filgrastim Venetoclax Asciminib Blinatumomab

Selinexor (KPT-330) Plus FLAG-Ida for the Treatment of Relapsing/Refractory AML

PHASE1

This protocol corresponds to a multicenter, open-label, non-randomized, pha...

Status

Completed

Location

Hospital Germans Tries i Pujol, Badalona

Start Date

2018-07-17

Trial ID

NCT03661515

Treatments Being Tested

Selinexor fludarabine idarubicin cytarabine G-CSF

SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia

PHASE4

Association group of therapeutic specialities authorized in a remission ind...

Status

Completed

Location

Hospital de la Ribera

Start Date

1998-07

Trial ID

NCT00487448

Treatments Being Tested

Fludarabine Cytarabine G-CSF Idarubicin Peripheral blood stem cell transplantation Bone marrow transplantation

Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia

PHASE1

This phase I trial studies the side effects and best dose of ivosidenib whe...

Status

Terminated

Location

Northwestern University

Start Date

2020-12-21

Trial ID

NCT04250051

Treatments Being Tested

Cytarabine Filgrastim Fludarabine Fludarabine Phosphate Ivosidenib Idarubicin

Blinatumomab Versus Standard of Care Chemotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)

PHASE3

The primary objective was to evaluate the effect of blinatumomab on overall...

Status

Terminated

Location

Research Site

Start Date

2014-01-03

Trial ID

NCT02013167

Treatments Being Tested

Blinatumomab Standard of Care Chemotherapy

Previous Next